Abramowitz, J. S. (2013). The practice of exposure therapy: Relevance of cognitive-behavioral theory and extinction theory. Behavior Therapy, 44(4), 548–558.

Article  PubMed  Google Scholar 

Abramowitz, J. S., Deacon, B. J., & Whiteside, S. P. (2019). Exposure therapy for anxiety: Principles and practice. Guilford Publications.

Adamson, S., & Metzner, R. (1988). The nature of the MDMA experience and its role in healing, psychotherapy and spiritual practice. ReVision, 10(4), 59–72.

Google Scholar 

Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021). Predicting reactions to psychedelic drugs: A systematic review of states and traits related to acute drug effects. ACS Pharmacology & Translational Science, 4(2), 424–435.

Article  CAS  Google Scholar 

Aday, J. S., Heifets, B. D., Pratscher, S. D., Bradley, E., Rosen, R., & Woolley, J. D. (2022). Great expectations: Recommendations for improving the methodological rigor of psychedelic clinical trials. Psychopharmacology (berl), 239(6), 1989–2010.

Article  CAS  PubMed  Google Scholar 

Agin-Liebes, G., Zeifman, R., Luoma, J. B., Garland, E. L., Campbell, W. K., & Weiss, B. (2022). Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca. Journal of Psychopharmacology, 36(3), 295–308.

Article  PubMed  Google Scholar 

Arch, J. J. (2014). Cognitive behavioral therapy and pharmacotherapy for anxiety: Treatment preferences and credibility among pregnant and non-pregnant women. Behaviour Research and Therapy, 52, 53–60.

Article  PubMed  Google Scholar 

Barrett, F. S., Johnson, M. W., & Griffiths, R. R. (2015). Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology, 29(11), 1182–1190.

Article  CAS  PubMed  Google Scholar 

Barrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M.S., Johnson, M. W., & Griffiths, R. R. (2016). The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology, 30(12), 1279–1295.

Article  PubMed  Google Scholar 

Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J., & Griffiths, R. R. (2020). Emotions and brain function are altered up to one month after a single high dose of psilocybin. Scientific Reports, 10(1), 2214.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1(82), 10.1037.

Belser, A. B., Agin-Liebes, G., Swift, T. C., Terrana, S., Devenot, N., Friedman, H. L., Guss, J., Bossis, A., & Ross, S. (2017a). Patient experiences of psilocybin-assisted psychotherapy: An interpretative phenomenological analysis. Journal of Humanistic Psychology, 57(4), 354–388.

Article  Google Scholar 

Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (methodological), 57(1), 289–300.

MathSciNet  Google Scholar 

Bogenschutz, M. P. (2024). Pharmacological and nonpharmacological components of psychedelic treatments: The whole is not the sum of the parts. American Journal of Psychiatry, 181(1), 75.

Article  PubMed  Google Scholar 

Bonny, H. L., & Pahnke, W. N. (1972). The use of music in psychedelic (LSD) psychotherapy. Journal of Music Therapy, 9(2), 64–87.

Article  Google Scholar 

Branchi, I. (2011). The double edged sword of neural plasticity: Increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover. Psychoneuroendocrinology, 36(3), 339–351.

Article  CAS  PubMed  Google Scholar 

Cameron, L. P., Tombari, R. J., Lu, J., Pell, A. J., Hurley, Z. Q., Ehinger, Y., Vargas, M. V., McCarroll, M. N., Taylor, J. C., & Myers-Turnbull, D. (2021). A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature, 589(7842), 474–479.

Article  ADS  CAS  PubMed  Google Scholar 

Carbonaro, T. M., Bradstreet, M. P., Barrett, F. S., MacLean, K. A., Jesse, R., Johnson, M. W., & Griffiths, R. R. (2016). Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology, 30(12), 1268–1278.

Article  PubMed  Google Scholar 

Carhart-Harris, R. L. (2023). Translational challenges in psychedelic medicine. New England Journal of Medicine, 388(5), 476–477.

Article  PubMed  Google Scholar 

Carhart-Harris, R. L., & Friston, K. J. (2019). REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics. Pharmacological Reviews, 71(3), 316–344.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carhart-Harris, R. L., & Goodwin, G. M. (2017). The therapeutic potential of psychedelic drugs: Past, present, and future. Neuropsychopharmacology, 42(11), 2105–2113.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018). Psychedelics and the essential importance of context. Journal of Psychopharmacology, 32(7), 725–731.

Article  PubMed  Google Scholar 

Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021a). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402–1411.

Article  CAS  PubMed  Google Scholar 

Carhart-Harris, R., Blemings, A., & Nutt, D. J. (2021b). Psilocybin for depression. Reply. The New England Journal of Medicine, 385(9), 863–864.

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., ... & Nutt, D. J. (2016). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences, 113(17), 4853–4858.

Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E., Gazzaley, A., Girn, M., Kettner, H., & Friston, K. J. (2022). Canalization and plasticity in psychopathology. Neuropharmacology, 226, 1–14.

Google Scholar 

Close, J. B., Hajien, E. C., Watts, R., Roseman, L., & Carhart-Harris, R. L. (2020). Psychedelics and psychological flexibility—Results of a prospective web-survey using the Acceptance and Action Questionnaire II. Journal of Contextual Behavioral Science, 16, 37–44.

Article  Google Scholar 

Cuijpers, P., Van Straten, A., & Warmerdam, L. (2007). Behavioral activation treatments of depression: A meta-analysis. Clinical Psychology Review, 27(3), 318–326.

Article  PubMed  Google Scholar 

Dakwar, E. (2022, 12/1/2022). Lifting the veil of hope and hype. Horizons New York, New York, NY.

Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021a). Effects of psilocybin-assisted therapy on major depressive disorder: A randomized clinical trial. JAMA Psychiatry, 78(5), 481–489.

Article  PubMed  Google Scholar 

Davis, A. K., Barrett, F. S., So, S., Gukasyan, N., Swift, T. C., & Griffiths, R. R. (2021b). Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. Journal of Psychopharmacology, 35(4), 437–446.

Article  PubMed  Google Scholar 

Daws, R. E., Timmermann, C., Giribaldi, B., Sexton, J. D., Wall, M. B., Erritzoe, D., ... & Carhart-Harris, R. (2022). Increased global integration in the brain after psilocybin therapy for depression. Nature Medicine, 28(4), 844–851.

De Vos, C. M., Mason, N. L., & Kuypers, K. P. (2021). Psychedelics and neuroplasticity: A systematic review unraveling the biological underpinnings of psychedelics. Frontiers in Psychiatry, 12, 724606.

Article  PubMed  PubMed Central  Google Scholar 

Erikson, E. H. (1994). Identity and the life cycle. WW Norton & company.

Fenichel, O. (2014). The psychoanalytic theory of neurosis. Routledge.

Book  Google Scholar 

Foa, E. B. (2011). Prolonged exposure therapy: Past, present, and future. Depression and anxiety.

Garland, E. L., & Fredrickson, B. L. (2019). Positive psychological states in the arc from mindfulness to selftranscendence: extensions of the Mindfulness-to-Meaning Theory and applications to addiction and chronic pain treatment. Current Opinion in Psychology, 28, 184–191.

Article  PubMed  PubMed Central  Google Scholar 

Goodwin, G. M., Malievskaia, E., Fonzo, G. A., & Nemeroff, C. B. (2023). Must psilocybin always “assist psychotherapy”? American Journal of Psychiatry., 181(1), 20–25.

Article  PubMed  Google Scholar 

Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020). Integrating psychotherapy and psychopharmacology: Psychedelic-assisted psychotherapy and other combined treatments. Expert Review of Clinical Pharmacology, 13(6), 655–670.

Article  CAS  PubMed  Google Scholar 

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197.

Article  CAS  PubMed  Google Scholar 

Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23(1), 56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harmer, C. J., Duman, R. S., & Cowen, P. J. (2017). How do antidepressants work? New perspectives for refining future treatment approaches. The Lancet Psychiatry, 4(5), 409–418.

Article  PubMed  PubMed Central  Google Scholar 

Hartogsohn, I. (2016). Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology. Journal of Psychopharmacology, 30(12),

Hayes, A. F., & Rockwood, N. J. (2017). Regression-based statistical mediation and moderation analysis in clinical research: Observations, recommendations, and implementation. Behaviour Research and Therapy, 98, 39–57.

Article  PubMed  Google Scholar 

Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006). Acceptance and commitment therapy: Model, processes and outcomes. Behaviour Research and Therapy, 44(1), 1–25.

Article  PubMed  Google Scholar 

Hayes, A. F., & Preacher, K. J. (2013). Conditional process modeling: Using structural equation modeling to examine contingent causal processes.

Hayes, S. C., Strosahl, K., Wilson, K. G., Bissett, R. T., Pistorello, J., Toarmino, D., ... & McCurry, S. M. (2004). Measuring experiential avoidance: A preliminary test of a working model. The psychological record, 54, 553–578.

Homberg, J. R., & Jagiellowicz, J. (2022). A neural model of vulnerability and resilience to stress-related disorders linked to differential susceptibility. Molecular Psychiatry, 27(1), 514–524.

Article